Dry Eye Syndrome Treatment Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

Date : Mar 2018

Formats :
Report Code : PMR83649618

Category : Pharmaceutical and Healthcare
No Of Pages :
Global Dry Eye Syndrome Treatment Market


Dry eye syndrome keratoconjunctivitis sicca, is an ocular disease caused by the lack of tear fluid to lubricate the eyes, which leads to problems in vision, tear film instability, and discomfort causes potential damage to the ocular surface. Dry eye syndrome can also cause due to other ocular surface diseases such as ocular allergy and meibomian gland dysfunction. The ocular surface contains 7 components including lacrimal and accessory lacrimal apparatus. Any abnormalities in one of the ocular surface components may cause the dry eye syndrome. Dry eye syndrome is classified into two types namely, evaporative dry eye and pure aqueous deficiency dry eye. The common symptoms associated with dry eye syndrome include ocular irritation, hyperaemia, mucoid discharge, blurred vision, excessive tearing, ocular dryness, photophobia, and grittiness. Dry eye syndrome is measured by a thin strip of filter paper placed at the edge of the eye, called a Schirmer test to measure the amount of tears present in the eye.



The global dry eye syndrome treatment market is expected to grow at a significant CAGR due to rise in the geriatric population tear glands weaken due to aging and can’t produce sufficient tear fluid to maintain a lubricating film over the eyes and increase in the prevalence of dry eye syndrome. The increase in the prevalence of diabetes, vitamin A deficiency, lupus, thyroid disorders, and rheumatoid arthritis might fuel the dry eye syndrome treatment market. Moreover, increasing awareness among the population about diagnosis and treatment of dry eye syndrome, steady government support for medical research has allowed researchers to treat this condition more precisely and comprehensively, external stimuli such as laser eye surgery, and computer screen overuse are key factors also boosting the dry eye syndrome treatment market over the forecast period. However, expiration of blockbuster drug patents, the popularity of selfmedication by patients is the major restraints for the dry eye syndrome treatment market over the forecast period.



Dry eye syndrome treatment market segmented on the basis of treatment type, disease type, and distribution channel



Based on treatment type, dry eye syndrome treatment market has been segmented into the following:

Lubricant Eye Drops
PreservativeFree Drops
Oily Tear Eye Drops
Eye Ointments
Antiinflammatory Drugs
Corticosteroids
Tetracyclines Oral
Autologous Serum Eye Drops
Nutrition supplements


Based on disease type, dry eye syndrome treatment market has been segmented into the following:

Evaporative dry eye syndrome
Aqueous dry eye syndrome


Based on distribution channel, dry eye syndrome treatment market has been segmented into the following:

Hospital pharmacies
Retail pharmacies
Online pharmacies
Others


Global dry eye syndrome treatment market is in the developing stage owing to increase in the research and development activities by the competitors in the dry eye syndrome treatment market. The patents of various dry eye syndrome treatment drugs are in expiry stage, so various pharmaceutical companies are actively involved in the R&D of new drugs. Some of the key strategies followed by various pharmaceutical companies to increase revenue share in global dry eye syndrome treatment market including acquisitions & mergers, collaborations, and launching of new products. For instance, in July 2013, Novaliq GmbH won European approval for its lubricating, drugdelivering eye drop NovaTears, designed for overthecounter treatment of dry eye syndrome. Similarly, in June 2015, Allergan plc, a pharmaceutical company acquired Oculeve Inc, a medical device company that focuses on new technologies for dry eye disease to improve market position in the dry eye syndrome treatment market. In addition, in January 2018, Novaliq announced the positive topline results of phase 2 clinical trial evaluating CyclASol in adults with moderate to severe dry eye disease. Moreover, in October 2015, Allergan plc launched artificial tear Refresh Optive gel drops to provide artificial tear option to relieve dry eye symptoms.



Geographically, the dry eye syndrome treatment market has been segmented into following regions Viz. North America, Europe, AsiaPacific, Latin America, and Middle East & Africa. North America dominates the dry eye syndrome treatment market due to high prevalence of lifestyle disorders which increase the chances of contracting dry eye syndrome, increase in the using medications such as antihistamines, pain relievers and antidepressants also increase the risk of dry eye syndrome in North America. Europe holds a dominant share in dry eye syndrome treatment market attributed to increase in the healthcare infrastructure, rise in the R&D activities, and increase in the usage of various medications which reduce the volume of tears produced in the eyes results in dry eye syndrome. AsiaPacific is an emerging region in dry eye syndrome treatment market owing to increase in population majorly in India and China, strong government support in AsiaPacific region.



Some of the players in dry eye syndrome treatment market are Novartis AG Switzerland, Nicox France, Allergan U.S., Santen Pharmaceutical Co., Ltd. Japan, Otsuka Holdings Co., Ltd. Japan, Auven Therapeutics U.S., AFT Pharmaceuticals New Zealand, IMed Pharma, Inc. Canada, Sun Pharmaceuticals Industries Ltd. India, Mimetogen Pharmaceuticals U.S., and Novaliq GMBH Germany to name a few.



In March 2018, Novaliq inked an agreement with AFT Pharmaceuticals for the commercialization of NovaTears in New Zealand and Australia


In August 2017, Auven Therapeutics completed the enrollment in confirmatory phase 3 clinical trial of Seciera OTX101 for the treatment of dry eye syndrome treatment


In November 2015, Allergan plc inked a licensing agreement with Mimetogen Pharmaceuticals, for the development and commercialization of tavilermide MIMD3, a TrkA agonist used in the treatment of dry eye syndrome treatment
1. Executive Summary
2. Global Dry Eye Syndrome Treatment Market Introduction
2.1. Global Dry Eye Syndrome Treatment Market – Taxonomy
2.2. Global Dry Eye Syndrome Treatment Market –Definitions
2.2.1. Treatment Type
2.2.2. Disease Type
2.2.3. Distribution Channel
3. Global Dry Eye Syndrome Treatment Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Dry Eye Syndrome Treatment Market Dynamics – Factors Impact Analysis
3.6. Global Dry Eye Syndrome Treatment Market – Regulations
3.6.1. U.S.
3.6.2. Europe
3.6.3. Japan
3.7. Global Dry Eye Syndrome Treatment Market – Product Pipeline Analysis
4. Global Dry Eye Syndrome Treatment Market Analysis, 2013 2017 and Forecast, 2018 – 2024
4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
4.2. YearoverYear YoY Growth Analysis %
4.3. Market Oppurtunity Analysis
5. Global Dry Eye Syndrome Treatment Market, By Treatment Type, 2013 2017 and Forecast, 2018 2024
5.1. Lubricant Eye Drops
5.1.1. PreservativeFree Drops
5.1.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
5.1.1.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
5.1.1.3. Market Opportunity Analysis
5.1.2. Oily Tear Eye Drops
5.1.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
5.1.2.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
5.1.2.3. Market Opportunity Analysis
5.1.3. Eye Ointments
5.1.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
5.1.3.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
5.1.3.3. Market Opportunity Analysis
5.2. Antiinflammatory Drugs
5.2.1. Corticosteroids
5.2.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
5.2.1.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
5.2.1.3. Market Opportunity Analysis
5.2.2. Tetracyclines Oral
5.2.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
5.2.2.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
5.2.2.3. Market Opportunity Analysis
5.3. Autologous Serum Eye Drops
5.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
5.3.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
5.3.3. Market Opportunity Analysis
5.4. Nutrition supplements
5.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
5.4.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
5.4.3. Market Opportunity Analysis
6. Global Dry Eye Syndrome Treatment Market Forecast, By Disease Type, 2013 2017 and Forecast, 2018 2024
6.1. Evaporative Dry Eye Syndrome
6.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
6.1.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
6.1.3. Market Opportunity Analysis
6.2. Aqueous Dry Eye Syndrome
6.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
6.2.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
6.2.3. Market Opportunity Analysis
7. Global Dry Eye Syndrome Treatment Market Forecast, By Distribution Channel, 2013 2017 and Forecast, 2018 2024
7.1. Hospital Pharmacies
7.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
7.1.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
7.1.3. Market Opportunity Analysis
7.2. Retail Pharmacies
7.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
7.2.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
7.2.3. Market Opportunity Analysis
7.3. Online Pharmacies
7.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
7.3.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
7.3.3. Market Opportunity Analysis
7.4. Others
7.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
7.4.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
7.4.3. Market Opportunity Analysis
8. Global Dry Eye Syndrome Treatment Market Forecast, By Region, 2013 2017 and Forecast, 2018 2024
8.1. North America
8.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
8.1.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
8.2.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
8.2.3. Market Opportunity Analysis
8.3. AsiaPacific
8.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
8.3.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
8.4.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
8.5.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
8.5.3. Market Opportunity Analysis
8.6. Global Dry Eye Syndrome Treatment Market Opportunity Analysis Index, By Treatment Type, By Distribution Channel, and Region, 2018 – 2024
9. North America Dry Eye Syndrome Treatment Market Analysis, 2013 2017 and Forecast, 2018 2024
9.1. Treatment Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth %, and Market Share %
9.1.1. Lubricant Eye Drops
9.1.1.1. PreservativeFree Drops
9.1.1.2. Oily Tear Eye Drops
9.1.1.3. Eye Ointments
9.1.2. Antiinflammatory Drugs
9.1.2.1. Corticosteroids
9.1.2.2. Tetracyclines Oral
9.1.3. Autologous Serum Eye Drops
9.1.4. Nutrition supplements
9.2. Disease Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
9.2.1. Evaporative Dry Eye Syndrome
9.2.2. Aqueous Dry Eye Syndrome
9.3. Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
9.3.1. Hospital Pharmacies
9.3.2. Retail Pharmacies
9.3.3. Online Pharmacies
9.4. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn YoY Growth % and Market Share %
9.4.1. U.S.
9.4.2. Canada
9.5. North America Dry Eye Syndrome Treatment Market Opportunity Analysis Index, By Treatment Type, Disease Type, By Distribution Channel and Country, 2018 – 2024
9.6. North America Dry Eye Syndrome Treatment Market Dynamics – Trends
10. Europe Dry Eye Syndrome Treatment Market Analysis, 2013 2017 and Forecast, 2018 2024
10.1. Treatment Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth %, and Market Share %
10.1.1. Lubricant Eye Drops
10.1.1.1. PreservativeFree Drops
10.1.1.2. Oily Tear Eye Drops
10.1.1.3. Eye Ointments
10.1.2. Antiinflammatory Drugs
10.1.2.1. Corticosteroids
10.1.2.2. Tetracyclines Oral
10.1.3. Autologous Serum Eye Drops
10.1.4. Nutrition supplements
10.2. Disease Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
10.2.1. Evaporative Dry Eye Syndrome
10.2.2. Aqueous Dry Eye Syndrome
10.3. Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
10.3.1. Hospital Pharmacies
10.3.2. Retail Pharmacies
10.3.2.1. Online Pharmacies
10.3.3. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
10.3.3.1. Germany
10.3.3.2. UK
10.3.3.3. France
10.3.3.4. Spain
10.3.3.5. Italy
10.3.3.6. Russia
10.3.3.7. Poland
10.3.3.8. Rest of Europe
10.4. Europe Dry Eye Syndrome Treatment Market Opportunity Analysis Index, Opportunity Analysis Index, By Treatment Type, By Distribution Channel and Country, 2018 – 2024
10.5. Europe Dry Eye Syndrome Treatment Market Dynamics – Trends
11. AsiaPacific Dry Eye Syndrome Treatment Market Analysis, 2013 2017 and Forecast, 2018 2024
11.1. Treatment Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth %, and Market Share %
11.1.1. Lubricant Eye Drops
11.1.1.1. PreservativeFree Drops
11.1.1.2. Oily Tear Eye Drops
11.1.1.3. Eye Ointments
11.1.2. Antiinflammatory Drugs
11.1.2.1. Corticosteroids
11.1.2.2. Tetracyclines Oral
11.1.3. Autologous Serum Eye Drops
11.1.4. Nutrition supplements
11.2. Disease Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
11.2.1. Evaporative Dry Eye Syndrome
11.2.2. Aqueous Dry Eye Syndrome
11.3. Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
11.3.1. Hospital Pharmacies
11.3.2. Retail Pharmacies
11.3.2.1. Online Pharmacies
11.3.3. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn,
YoY Growth %, and Market Share %
11.3.3.1. Japan
11.3.3.2. China
11.3.3.3. India
11.3.3.4. ASEAN
11.3.3.5. Australia & New Zealand
11.3.3.6. Rest of AsiaPacific
11.4. AsiaPacific Dry Eye Syndrome Treatment Market Opportunity Analysis Index, By Treatment Type, By Distribution Channel and Country, 2018 – 2024
11.5. Asia Pacific Dry Eye Syndrome Treatment Market Dynamics – Trends
12. Latin America Dry Eye Syndrome Treatment Market Analysis, 2013 2017 and Forecast, 2018 2024
12.1. Treatment Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth %, and Market Share %
12.1.1. Lubricant Eye Drops
12.1.1.1. PreservativeFree Drops
12.1.1.2. Oily Tear Eye Drops
12.1.1.3. Eye Ointments
12.1.2. Antiinflammatory Drugs
12.1.2.1. Corticosteroids
12.1.2.2. Tetracyclines Oral
12.1.3. Autologous Serum Eye Drops
12.1.4. Nutrition supplements
12.2. Disease Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
12.2.1. Evaporative Dry Eye Syndrome
12.2.2. Aqueous Dry Eye Syndrome
12.3. Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
12.3.1. Hospital Pharmacies
12.3.2. Retail Pharmacies
12.3.2.1. Online Pharmacies
12.3.3. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
12.3.3.1. Brazil
12.3.3.2. Mexico
12.3.3.3. Argentina
12.3.3.4. Venezuela
12.3.3.5. Rest of Latin America
12.4. Latin America Dry Eye Syndrome Treatment Market Opportunity Analysis Index, By Treatment Type, By Distribution Channel and Country, 2018 – 2024
12.5. Latin America Dry Eye Syndrome Treatment Market Dynamics – Trends
13. Middle East and Africa Dry Eye Syndrome Treatment Market Analysis, 2013 2017 and Forecast, 2018 2024
13.1. Treatment Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth %, and Market Share %
13.1.1. Lubricant Eye Drops
13.1.1.1. PreservativeFree Drops
13.1.1.2. Oily Tear Eye Drops
13.1.1.3. Eye Ointments
13.1.2. Antiinflammatory Drugs
13.1.2.1. Corticosteroids
13.1.2.2. Tetracyclines Oral
13.1.3. Autologous Serum Eye Drops
13.1.4. Nutrition supplements
13.2. Disease Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
13.2.1. Evaporative Dry Eye Syndrome
13.2.2. Aqueous Dry Eye Syndrome
13.3. Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
13.3.1. Hospital Pharmacies
13.3.2. Retail Pharmacies
13.3.2.1. Online Pharmacies
13.4. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth %, and Market Share %
13.4.1.1. Gulf Cooperation Council GCC Countries
13.4.1.2. Israel
13.4.1.3. South Africa
13.4.1.4. Rest of MEA
13.5. MEA Dry Eye Syndrome Treatment Market Opportunity Analysis Index, By Treatment Type, By Distribution Channel and Country, 2018 – 2024
13.6. MEA Dry Eye Syndrome Treatment Market Dynamics – Trends
14. Competition Landscape
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis
14.2.1. Novartis AG Switzerland
14.2.2. Nicox France
14.2.3. Allergan U.S.
14.2.4. Santen Pharmaceutical Co., Ltd. Japan
14.2.5. Otsuka Holdings Co., Ltd. Japan
14.2.6. Auven Therapeutics U.S.
14.2.7. AFT Pharmaceuticals New Zealand
14.2.8. IMed Pharma, Inc. Canada
14.2.9. Sun Pharmaceuticals Industries Ltd. India
14.2.10. Mimetogen Pharmaceuticals U.S.
14.2.11. Novaliq GMBH Germany
15. Research Methodology
16. Key Assumptions and Acronyms
  Purchase Options for Report

Need More information

Call us :
USA : +1 7162260907
UK : +44 7441952057
....
sales@planetmarketreports.com

Why to PMR

PMR Market Research

Our syndicated research reports cover 50+ industry sectors offering you product and country wise breakup of the market along with niche data and insights that will help you make informed business decision. Our research is focused on the key segments of an industry that possess opportunities of growth.

  • Industrial ...
  • Business ....
  • Consumer ....
  • Peer ....